Marsters, Candace M.
Nesan, Dinushan
Far, Rena
Klenin, Natalia
Pittman, Quentin J.
Kurrasch, Deborah M.
Funding for this research was provided by:
Canadian Institutes of Health Research (MOP-125905)
Article History
Received: 16 December 2019
Accepted: 13 April 2020
First Online: 6 May 2020
Ethics approval and consent to participate
: Animal protocols were approved by the University of Calgary Animal Care Committee and followed the Guidelines for the Canadian Council of Animal Care.
: Not applicable.
: Deborah Kurrasch is the co-founder of Path Therapeutics, an epilepsy biotech company. The other authors have nothing further to declare.